14 JUNE 2018

GFN

BallroomCDEF

Plenary:

Michael Russell Oration 2018 and Presentation of Awards 2018

-

Gerry Stimson

Presentation of Michael Russell Award

Gerry Stimson

Judy Gibson

Presentation of INNCO Awards

Judy Gibson

Joe Kosterich

Rethinking Nicotine: New nicotine products, the media and the medical profession

Joe Kosterich

Colin Mendelsohn

Colin Mendelsohn

Sphinx Restaurant

GFN Social Event

-

15 JUNE 2018

GFN - Part 2

BallroomCDEF

Film Festival:

Programme excerpts & introduction

-

Aaron Biebert

Director of 'A Billion Lives'

Aaron Biebert

BallroomCDEF

Plenary 1:

Rethinking nicotine

-

David Levy

Modelling future impact of the uptake of e-cigarettes and other safer nicotine products

David Levy

Mohamadi Sarkar

The role of smokeless tobacco in harm reduction - the divergence between consumer perceptions and scientific evidence

Mohamadi Sarkar

Sarah Jakes

Rethinking why people like nicotine

Sarah Jakes

David Sweanor

The changing global nicotine market: disruptive technology hits the cigarette business

David Sweanor

Joe Gitchell

How to feel AND think about nicotine and those who use it

Joe Gitchell

Gerry Stimson

Gerry Stimson

Foyer

Coffee Break

-

BallroomC

Parallel 1:

Advocacy and Practice Track: Country updates on tobacco harm reduction

-

Cecilia Kindstrand-Isaksson

Reflections on change: is the tipping point in sight?

Cecilia Kindstrand-Isaksson

Roberto Sussman

Regulation of electronic cigarettes in Mexico

Roberto Sussman

Mirosław Dworniczak

Poland and the regulation of e-cigarettes

Mirosław Dworniczak

Hiroya Kumamaru

Japanese experience with heat-not-burn

Hiroya Kumamaru

Colin Mendelsohn

The Australian Tobacco Harm Reduction Association – educating the public and health community about vaping

Colin Mendelsohn

Karl Snaebjornsson

Iceland, outlier in the middle of nowhere: smoking, vaping and snus

Karl Snaebjornsson

Nancy Loucas

Nancy Loucas

BallroomD

Parallel 2:

Science Track: Clinical and real world contexts for reduced harm nicotine products

-

Karl Lund

Perceptions of relative risk between cigarettes and snus, e-cigarettes and NRT-product

Karl Lund

Christelle Haziza

Changes in biological and functional markers after 6 months, in 3 populations: IQOS users, continued smokers, and smoking abstinence

Christelle Haziza

Daniel Frings

How do vaping ads and anti-smoking messages affect attitudes towards both e-cigarettes and tobacco held by smokers, vapers, dual users and non-smoker…

Daniel Frings

Karolien Adriaens

Experimental trial on the effectiveness of heat-not-burn cigarettes compared to e-cigarettes and regular tobacco cigarettes: effects on acute craving…

Karolien Adriaens

Thomas Brandon

Using the balanced placebo trial design for parsing nicotine administration effects

Thomas Brandon

Richard Holliday

E-cigarettes for smoking cessation within healthcare settings: patients’ perceptions and research feasibility

Richard Holliday

Grzegorz Król

Grzegorz Król

Baltic

?:

Film Festival

-

Aaron Biebert

Aaron Biebert

Hall-Floor2

Lunch Break

-

BallroomC

Parallel 4:

Beliefs and practices: new evidence on real world use of electronic cigarettes

-

Marewa Glover

Recognising vapers’ knowledge as a lay epidemiology and collaborating with them to reduce smoking-related harm

Marewa Glover

Julie Woessner

What Smokers who switched to vapor products tell us about themselves

Julie Woessner

Carrie Wade

Challenging bad literature for the good of public health

Carrie Wade

Sudhanshu Patwardhan

The three country experiences with THR- consumer insights and product implications

Sudhanshu Patwardhan

Gregory Conley

Vapers, the vaping industry, and taxes: not always as they seem

Gregory Conley

Peter Beckett

Two years of TPD: what have we learned?

Peter Beckett

Robyn Gougelet

Robyn Gougelet

BallroomD

Parallel 5:

Science Track: Reduced harm nicotine products and their role in tobacco smoking cessation

-

Veronica Boland

“I'm not strong enough; I’m not good enough. I can’t do this, I'm failing.” Barriers to cessation among disadvantaged smokers and their experiences w…

Veronica Boland

James Murphy

Using System Dynamics modelling to assess the impact of launching e-cigarettes in the US market

James Murphy

Jacques le Houezec

Vapeshops, their role in public health, the needs of customers and the need for staff training

Jacques le Houezec

Hannah Farrimond

E-cigarette friendly smoking cessation services: staff perspectives

Hannah Farrimond

Aleksei Trofimov

Exploring the utility of the innovative nicotine delivery systems as nicotine replacement therapy tools

Aleksei Trofimov

Tanvir Walele

Overview of in vitro methods used to assess ENDS based on “Toxicity Testing in 21st Century” principles

Tanvir Walele

Patricia Kovacevic

Patricia Kovacevic

Baltic

Parallel 6:

Film Festival

-

Aaron Biebert

Aaron Biebert

Foyer

Coffee Break

-

Debate:

Who can we trust? Evidence and promises

-

Martin Cullip

Panelist

Martin Cullip

Derek Yach

Panelist

Derek Yach

Louise Ross

Panelist

Louise Ross

Laura Leigh Oyler

Panelist

Laura Leigh Oyler

Amy Fairchild

Panelist

Amy Fairchild

Martin Cawley

Moderator

Martin Cawley

Reception

Reception

-

16 JUNE 2018

GFN - Part 3

Plenary 2:

Science and the new understandings of nicotine

-

Ed Stephens

The role of emissions in the debate on health effects across the spectrum of nicotine delivery

Ed Stephens

Martin Jarvis

Michael Russell’s take on nicotine, smoking and harm reduction: how well does it stand up, 25 years on?

Martin Jarvis

Paul Newhouse

Nicotine therapeutics: therapeutic aspects of nicotinic stimulation for brain disorders

Paul Newhouse

Caitlin Notley

Nicotine in everyday life – from addiction to recreation

Caitlin Notley

David Sweanor

David Sweanor

Foyer

Coffee Break

-

Plenary 2:

Neglected issues – and those who are left behind

-

Frances Thirlway

Poor smokers and harm reduction: why smoking still makes sense

Frances Thirlway

Annie Kleykamp

Rethinking nicotine across the lifespan: what about the older smoker?

Annie Kleykamp

Helen Redmond

The Switch: the challenges for active drug users to switch from smoking to vaping

Helen Redmond

Rajesh Sharan

India and tobacco – rethinking the issues and the solutions

Rajesh Sharan

Caitlin Notley

Caitlin Notley

Lunch Break

-

Debate:

Rethinking Nicotine: Where to next?

-

Konstantinos Farsalinos

Panelist

Konstantinos Farsalinos

Jeannie Cameron

Panelist

Jeannie Cameron

Kgosi Letlape

Panelist

Kgosi Letlape

Joe Murillo

Panelist

Joe Murillo

Sharon Cox

Moderator

Sharon Cox

Clive Bates

Moderator

Clive Bates

Foyer

Coffee Break

-

Ballroom CD

Session:

Closing Session

-

Cynthia Cabrera

Reflections on the conference

Cynthia Cabrera

Andy Morrison

Reflections on the conference

Andy Morrison

Alex Wodak

Reflections on the conference

Alex Wodak

Aaron Biebert

Award

Aaron Biebert

Harry Shapiro

Rapporteur

Harry Shapiro

Dave Sweanor

Chair

Dave Sweanor